Ian M. Robertson
Edmonton, AB T5J1S6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Role of Electrostatics in the Mechanism of Cardiac Thin Filament Based Sensitizers.
Journal: ACS chemical biology
Published: July 08, 2020
Optimizing fluorine labelling for 19F solid-state NMR in oriented biological systems.
Journal: Journal of biomolecular NMR
Published: August 12, 2019
Thioimidate Bond Formation between Cardiac Troponin C and Nitrile-containing Compounds.
Journal: ACS medicinal chemistry letters
Published: April 12, 2019
Reversible Covalent Reaction of Levosimendan with Cardiac Troponin C in Vitro and in Situ.
Journal: Biochemistry
Published: March 21, 2018
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Journal: Cardiovascular research
Published: October 26, 2017
Reversible Covalent Binding to Cardiac Troponin C by the Ca2+-Sensitizer Levosimendan.
Journal: Biochemistry
Published: September 28, 2016
A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.
Journal: American journal of physiology. Heart and circulatory physiology
Published: September 05, 2016
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.
Journal: American journal of physiology. Heart and circulatory physiology
Published: June 27, 2016
Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog.
Journal: Journal of molecular and cellular cardiology
Published: December 01, 2015
The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q.
Journal: Journal of molecular and cellular cardiology
Published: May 31, 2015
Structure and Dynamics of the Acidosis-Resistant A162H Mutant of the Switch Region of Troponin I Bound to the Regulatory Domain of Troponin C.
Journal: Biochemistry
Published: May 22, 2015
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Journal: Biochimica et biophysica acta
Published: September 02, 2014
Last Updated: 09/26/2026